Study of an early wellness program in Parkinson’s disease: impact on quality of life and early intervention guidance
Objective: This study examined whether intervening early in PD with a comprehensive Wellness Program is feasible and promotes lasting habits that will continue to provide…Intensive Short-Term Dance Intervention in Parkinson’s Disease
Objective: To evaluate changes in motor symptoms and quality of life for people with Parkinson’s disease (PD) as a result of an intensive short-term dance intervention. …From local partnership to national network: the growth of a medically connected, community based program model for Parkinson’s wellness
Objective: To increase the scale of a medical and community partnership program model for the delivery of comprehensive Parkinson’s Wellness programming. Background: In 2007, an…The landscape of interventional trials in Parkinson disease: A 10-year review of ClinicalTrials.gov between 2006 and 2016
Objective: To review the scope of interventional trials for Parkinson disease registered on clinicaltrials.gov in the past 10 years. Background: Parkinson disease (PD) is a broad chronic condition…Evaluating Use of the DBS Patient Programmer
Objective: To characterize use of the Medtronic® DBS patient programmer among patients with DBS for movement disorders. Background: Patients who undergo deep brain stimulation receive…Study in Parkinson’s Disease of Exercise (SPARX): A Randomized, Controlled Futility Trial
Objective: Our first objective was to determine whether people with de novo Parkinson’s disease (PD) are able to exercise at either 60-65% maximal heart rate…Using the power of a Network to accomplish a Countrywide Review of Acute Parkinson’s Disease management
Objective: To undertake a review of acute Parkinson’s management across different sites in Wales, a country that is part of the United Kingdom with a…Evaluation of rotigotine transdermal patch in combination with low or high dose levodopa in patients with Parkinson’s disease: post-hoc analysis
Objective: To investigate the value of adding the dopamine agonist (DA) rotigotine (RTG) to low (<400mg/day) or high (≥400mg/day) levodopa (Ldopa) doses in patients with…Gait, Freezing of Gait and Falls detection using wearable sensors; a systematic review
Objective: An overview of the use of wearable systems to assess gait, freezing of gait (FOG) and falls in patients with Parkinson’s disease (PD). Background:…The Critical Path for Parkinson’s Consortium: Understanding Motor Disease Progression Through Quantitative Medicine
Objective: Develop a quantitative tool to optimize the definition of entry criteria, enrichment strategies and stratification approaches, and submit for formal regulatory endorsement at FDA…
- « Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 23
- Next Page »